EM Stimulation Therapy Applied to Improving the Symptoms of Fibromyalgia Syndrome
Rationale
As explained above, there is no cure for fibromyalgia, and medication is the primary treatment available with limited success and its own set of symptomatic side-effects.
Consequently, there has been a recent focus to find alternative, non-invasive, non-destructive treatment options for fibromyalgia patients that not only effectively aid to alleviate the symptoms, but simultaneously minimize debilitating side effects and complications.
Since 1985, thousands of subjects have been treated using various forms of magnetic stimulators to assess impact on the motor function of the peripheral and central nervous systems. Resultantly, there is a considerable volume of data supporting the safety of magnetic stimulation. No serious adverse events or side effects with magnetic stimulation of the peripheral or central nervous systems have been reported, and the incidence of reported side effects with cortical stimulation have been extremely low and well within expected norms for the respective patient groups.
The Resonator™ device, as intended for application in this pilot study, is of extremely low frequency and low amplitude (approximate frequency of 1.8 Hz to 8.0 Hz and picoTesla 10-8 gauss range), with orders of magnitude lower in field strength than most current investigational therapies, such as those involving rTMS/TMS described below.
|